CLINICAL TRIALS PROFILE FOR STARLIX
✉ Email this page to a colleague
All Clinical Trials for STARLIX
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00928889 ↗ | Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors | Completed | Novartis Pharmaceuticals | Phase 4 | 2009-07-01 | This study was conducted to demonstrate superiority of nateglinide in postprandial glucose fluctuation, dyslipidemia, and inflammatory status improvement. |
NCT01159158 ↗ | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2007-02-01 | The objective of this study is to compare the rate and extent of absorption of nateglinide 120 mg tablet (test) versus Starlix ® (reference), administered as 1 x 120 mg tablet under fasting conditions. |
NCT01160029 ↗ | Bioequivalence Study of Nateglinide Tablets 120 mg of Dr. Reddy's Laboratories Limited Under Fed Condition | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2004-10-01 | The objective of this study is to compare the rate and extent of absorption of nateglinide 120 mg tablet (test) versus Starlix ® (reference), administered as 1 x 120 mg tablet under fed conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for STARLIX
Condition Name
Clinical Trial Locations for STARLIX
Clinical Trial Progress for STARLIX
Clinical Trial Phase
Clinical Trial Sponsors for STARLIX
Sponsor Name